Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|July 27, 2005
Incidence and characteristics of angioedema associated with enalaprilJohn B Kostis, Harold J Kim, James Rusnak, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2021
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbiditiesThomas Casale, Nestor A Molfino, Jared Silver, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 4, 2003
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitisPaul Chervinsky, Thomas Casale, Robert Townley, et al.
Allergy and Asthma Proceedings|November 19, 2003
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitisAnjuli Nayak, Thomas Casale, S David Miller, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2007
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled studyHarold Nelson, James Kemp, William Berger, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2013
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus reportA Wesley Burks, Moises A Calderon, Thomas Casale, et al.
Expert Review of Clinical Immunology|August 13, 2019
Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from <i>in vitro</i> allergen-release dataGiorgio Walter Canonica, Philippe Devillier, Thomas Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen ImmunotherapyCarmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
The Journal of Allergy and Clinical Immunology|April 30, 2013
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adultsPeter S Creticos, Jennifer Maloney, David I Bernstein, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV<sub>1</sub>David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Pageof 7